Samuel Waxman Selected Research

Samuel Waxman Research Topics

Disease

31	Neoplasms (Cancer) 01/2023 - 07/2002
22	Acute Promyelocytic Leukemia 03/2016 - 01/2002
10	Leukemia 12/2012 - 02/2002
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2005
7	Sudden Infant Death (SID) 02/2022 - 06/2010
7	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2002
5	Hematologic Neoplasms (Hematological Malignancy) 12/2006 - 01/2002
4	Carcinogenesis 07/2016 - 01/2005
4	Lymphoma (Lymphomas) 12/2012 - 04/2003
4	Carcinoma (Carcinomatosis) 02/2011 - 01/2005
4	Multiple Myeloma 03/2008 - 01/2002
3	Hepatocellular Carcinoma (Hepatoma) 05/2011 - 12/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 12/2012
2	Triple Negative Breast Neoplasms 07/2016 - 08/2015
2	Inflammation (Inflammations) 04/2015 - 04/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 12/2012 - 03/2005
2	Melanoma (Melanoma, Malignant) 01/2005 - 12/2003
2	Prostatic Neoplasms (Prostate Cancer) 05/2004 - 12/2003
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Necrosis 06/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2011
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Progressive Multifocal Leukoencephalopathy 03/2009

Drug/Important Bio-Agent (IBA)

18	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 01/2002
15	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 02/2002
12	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2002
5	Retinoic Acid Receptor alphaIBA 03/2009 - 02/2002
5	Aligeron (AS 2)IBA 08/2008 - 04/2003
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2006
4	Peptides (Polypeptides)IBA 01/2022 - 08/2015
4	ChromatinIBA 01/2022 - 03/2008
4	RetinoidsIBA 07/2016 - 10/2003
4	Tamoxifen FDA LinkGeneric 08/2015 - 02/2008
4	Co-Repressor ProteinsIBA 08/2015 - 05/2003
4	Histone Deacetylase InhibitorsIBA 03/2007 - 08/2002
4	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 09/2005 - 08/2002
3	CytokinesIBA 04/2015 - 01/2005
3	Cyclin D1IBA 06/2011 - 09/2006
3	ArsenicIBA 03/2009 - 07/2002
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 08/2002
2	retinoic acid receptor betaIBA 01/2022 - 06/2010
2	Estrogens (Estrogen)FDA Link 08/2015 - 04/2011
2	Caspase 3 (Caspase-3)IBA 12/2012 - 03/2005
2	Therapeutic UsesIBA 12/2012 - 05/2005
2	Caspase 8 (Caspase-8)IBA 11/2012 - 03/2005
2	CyclinsIBA 02/2008 - 09/2006
2	UbiquitinIBA 05/2007 - 12/2006
2	Bortezomib (Velcade)FDA Link 05/2007 - 09/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2007 - 12/2006
2	Proteasome InhibitorsIBA 05/2007 - 09/2006
2	Death Domain ReceptorsIBA 12/2006 - 03/2005
2	Glutathione S-Transferase piIBA 02/2005 - 05/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2005 - 12/2003
2	InterleukinsIBA 01/2005 - 12/2003
2	Butyric Acid (Butanoic Acid)IBA 10/2003 - 08/2002
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	LuciferasesIBA 01/2022
1	venetoclaxIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Am 580 (Am580)IBA 01/2022
1	Checkpoint Kinase 1IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	CateninsIBA 10/2017
1	B7-H1 AntigenIBA 01/2017
1	tamibaroteneIBA 07/2016
1	A-factor (Streptomyces)IBA 10/2015
1	avermectinIBA 08/2015
1	selamectinIBA 08/2015
1	Ivermectin (Mectizan)FDA Link 08/2015
1	Progesterone FDA LinkGeneric 08/2015
1	TOR Serine-Threonine KinasesIBA 04/2015
1	IronIBA 03/2015
1	artenimol (dihydroartemisinin)IBA 03/2015
1	Apoptosis Regulatory ProteinsIBA 03/2015
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 12/2012
1	ethacrynic acid butyl esterIBA 12/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2012
1	Cytochromes c (Cytochrome c)IBA 12/2012
1	LipidsIBA 11/2012
1	Surface Antigens (Surface Antigen)IBA 11/2012
1	Cyclin EIBA 06/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2011
1	Bexarotene (LGD1069)FDA Link 06/2011
1	MicroRNAs (MicroRNA)IBA 05/2011
1	Fulvestrant (Faslodex)FDA Link 04/2011
1	Mucin-1 (CA 15-3 Antigen)IBA 02/2011
1	Epithelial Cell Adhesion MoleculeIBA 02/2011
1	CollagenIBA 02/2011
1	Mitochondrial DNA (mtDNA)IBA 02/2011
1	Estrogen Receptor alphaIBA 06/2010
1	Cadherins (E-Cadherin)IBA 06/2010
1	Oncogene Proteins (Oncogene Protein)IBA 03/2009
1	Everolimus FDA Link 12/2008
1	AEE 788 (AEE788)IBA 12/2008

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2002
7	Drug Therapy (Chemotherapy) 06/2011 - 01/2002
1	Ligation 11/2012